Treatment with retinoic acid (RA) attenuated Con A-induced hepatitis by directly altering retinoic acid receptor alpha (RAR-α) and mitogen-activated protein kinase- (MAPK-) related signaling molecules, which reduced IFN-γ and IL-4 [29]. The gene discussed is RARA; the disease is hepatitis A virus infection.